Tyra Biosciences | Next-Generation Precision Medicines We are working to advance our clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers Please complete this form to receive updates *All fields are required I would like to learn more about Tyra's clinical studies for skeletal dysplasia and urologic cancers
Tyra Biosciences (TYRA) Stock Price, News Analysis $TYRA Tyra Biosciences (NASDAQ: TYRA) is a clinical-stage precision oncology company focused on the discovery and development of small-molecule therapies for genetically defined cancers
Tyra Biosciences Inc (TYRA) Stock Price News - Google Finance Get the latest Tyra Biosciences Inc (TYRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions